Sangjae Kim

Efficacy and safety of GV1001 in patients with moderate-to-severe Alzheimer’s disease already receiving donepezil: a phase 2 randomized, double-blind, placebo-controlled, multicenter clinical trial

Seong‐Ho Koh, Hyuk Sung Kwon, Seong Hye Choi et al. · Alzheimer s Research & Therapy · 2021 · 37 citations · Full text

Medicine, Neurology, Pharmacology +16

Tracking and protection of transplanted stem cells using a ferrocenecarboxylic acid-conjugated peptide that mimics hTERT

Hyun-Hee Park, Kyu‐Yong Lee, Dong Woo Park et al. · Biomaterials · 2017 · 14 citations

Life Sciences, Biochemistry, Biotechnology +9

GV1001 modulates neuroinflammation and improves memory and behavior through the activation of gonadotropin-releasing hormone receptors in a triple transgenic Alzheimer’s disease mouse model

Hyun‐Hee Park, Hyuk Sung Kwon, Kyu‐Yong Lee et al. · Brain Behavior and Immunity · 2023 · 13 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

hTERT peptide fragment GV1001 demonstrates radioprotective and antifibrotic effects through suppression of TGF‑β signaling

Wei Chen, Kihyuk Shin, Sangjae Kim et al. · International Journal of Molecular Medicine · 2018 · 11 citations · Full text

Medicine, Oncology, Radiation Oncology +17